TM Editors' note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.
Company: Beijing Tiantan Biological Products Corporation Limited
Bloomberg ticker: 600161 SH
Market cap: US$5,742m
Background: Beijing Tiantan Biological Products Corporation Limited researches, develops, and commercializes biological products. The Company provides treatment for hepatitis and offers a line of vaccine products including hepatitis vaccines and rubella vaccines.
World Class Benchmarking of Beijing Tiantan Biological Products Corp.
(Click on image to enlarge)
- Profitable Growth rank of 3 was up compared to the prior period’s 5th rank
- This is above average performance compared to 380 large Health Care companies worldwide
- Profitability rank of 4 was worse than its Growth rank of 2
- Profitability rank of 4 was the same compared to the prior period’s 4th rank
- This is above average performance compared to peers
- Growth rank of 2 was up compared to the prior period’s 5th rank
- This is World Class performance compared to peers
More By This Author:
Japanese Stock: MIXI
Asian Stock: Bumrungrad Hospital
Asian Stock: China Resources Boya Bio-Pharmaceutical Group
Comments
Log in or sign up to join the conversation.